OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
24/05/2025
Voltar para busca
Dado oficial do USPTO
LIXONDEL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
25/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
02/10/2023
Data de registro
01/10/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/10/2024
Última transação
25/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
CARLYLE, SHAUNIA
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/05/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/05/2025
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
29/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/03/2025
FIMP
FINAL DISPOSITION PROCESSED
13/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/07/2024
PUBO
PUBLISHED FOR OPPOSITION
16/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2024
RFNT
REFUSAL PROCESSED BY IB
14/05/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/04/2024
RFRR
REFUSAL PROCESSED BY MPU
19/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/04/2024
CNRT
NON-FINAL ACTION WRITTEN
01/04/2024
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
13/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/01/2024
CNRT
NON-FINAL ACTION WRITTEN
24/01/2024
DOCK
ASSIGNED TO EXAMINER
18/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
19/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/12/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/12/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/12/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIXONDEL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.